skip to main content

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate > oligosaccharide > n-[(2r,3r,4r,5s,6r)-2-[(2r,3r,4s,5s)-5-[(1r)-1,2-dihydroxyethyl]-4-hydroxy-2-[(3r,4s,5r,6r)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]oxyoxolan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate > oligosaccharide > n-[(2r,3r,4r,5s,6r)-2-[(2r,3r,4s,5s)-5-[(1r)-1,2-dihydroxyethyl]-4-hydroxy-2-[(3r,4s,5r,6r)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]oxyoxolan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate > oligosaccharide > n-[(2r,3r,4r,5s,6r)-2-[(2r,3r,4s,5s)-5-[(1r)-1,2-dihydroxyethyl]-4-hydroxy-2-[(3r,4s,5r,6r)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]oxyoxolan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > carbohydrates and carbohydrate derivatives > glycan > oligosaccharide > n-[(2r,3r,4r,5s,6r)-2-[(2r,3r,4s,5s)-5-[(1r)-1,2-dihydroxyethyl]-4-hydroxy-2-[(3r,4s,5r,6r)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]oxyoxolan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > carbohydrates and carbohydrate derivatives > glycan > oligosaccharide > n-[(2r,3r,4r,5s,6r)-2-[(2r,3r,4s,5s)-5-[(1r)-1,2-dihydroxyethyl]-4-hydroxy-2-[(3r,4s,5r,6r)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]oxyoxolan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > carbohydrates and carbohydrate derivatives > glycan > oligosaccharide > n-[(2r,3r,4r,5s,6r)-2-[(2r,3r,4s,5s)-5-[(1r)-1,2-dihydroxyethyl]-4-hydroxy-2-[(3r,4s,5r,6r)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]oxyoxolan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide

Preferred term

n-[(2r,3r,4r,5s,6r)-2-[(2r,3r,4s,5s)-5-[(1r)-1,2-dihydroxyethyl]-4-hydroxy-2-[(3r,4s,5r,6r)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]oxyoxolan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

Broader concept

charge

  • 0

formula

  • C20H35NO16

inchi

  • InChI=1S/C20H35NO16/c1-5(25)21-9-12(29)10(27)8(4-24)34-19(9)37-17-14(31)15(6(26)2-22)35-20(17)36-16-13(30)11(28)7(3-23)33-18(16)32/h6-20,22-24,26-32H,2-4H2,1H3,(H,21,25)/t6-,7-,8-,9-,10-,11+,12-,13+,14+,15+,16-,17-,18?,19-,20-/m1/s1

inchikey

  • HIANTICUONOIBZ-MZRSCYLUSA-N

mass

  • 545.491

monoisotopicmass

  • 545.19558

smiles

  • O1[C@H](O[C@@H]2[C@@H](O)[C@@H](O)[C@H](OC2O)CO)[C@H](O[C@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3NC(=O)C)CO)[C@@H](O)[C@@H]1[C@H](O)CO

subset

  • 2_STAR

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:156748

Download this concept: